长链非编码RNA-PVT1促进浆液性卵巢癌恶性行为的作用和机制
批准号:
81472432
项目类别:
面上项目
资助金额:
72.0 万元
负责人:
刘招舰
依托单位:
学科分类:
肿瘤表观遗传
结题年份:
2018
批准年份:
2014
项目状态:
已结题
项目参与者:
张锡宇、李杰、魏建军、董瑞芬、张青、郭海洋、刘晓林、许立美
中文摘要
最近研究表明,输卵管是低级别和高级别浆液性卵巢癌(HG-SOC)的共同起源,但HG-SOC恶性程度更高、预后更差。对比分析两种浆液性癌,揭示HG-SOC恶性行为背后的分子机制是本课题目标。PVT1是我们前期应用lncRNA芯片筛选获得的在HG-SOC中特异高表达的长链非编码RNA,进一步预实验结果显示PVT1促进卵巢癌细胞的克隆形成和侵袭力,并诱导上皮-间质转化(EMT),但PVT1发挥作用的分子机制尚不明确。本课题拟通过干预表达,利用体外和体内实验明确其在HG-SOC中的生物学功能;进一步利用RNA pull-down、RIP结合质谱等方法筛选和鉴定PVT1特异性结合蛋白及下游关键分子;并利用原位杂交和免疫组化分析PVT1及相关分子与肿瘤发生发展和临床预后的相关性。研究将有助于揭示lncRNA参与高级别浆液性卵巢癌的发生发展机制,为该病的早期诊断和治疗提供新的分子靶点。
英文摘要
Recent studies showed that fallopian tube (FT) secretory epithelia may be the primary cell origin and habor the precursors of ovarian low grade(LG-SOC) and high-grade serous ovarian carcinomas(HG-SOC). In different from LGSOC, HGSOC are rapidly growing , highly aggressive and deadly form of disease. Although associated genetic mutations are different between LGSOC and HGSOC, the molecular mechanism for tumor behavior remain undetermined. The purpose of this study is to explore and characterize whether the long non-coding RNAs(lncRNAs) are contributed to the aggressive behavor of HG-SOC. To search for candidates of lncRNAs that are related to HGSOC, we performed LncRNA microarray analysis in HG-SOC and LG-SOC and fallopian tube (FT)as control. We identified and validated LncRNA- PVT1 as one of lncRNAs that was signficantly expressed in HG-SOC. Introducing PVT1 overexpression promotes ovarian cancer colony formation and cell invasion. Up regulation of vimentin and down regulation of E-cadherin was also detected in PVT1 overexpressed cells comared to control cells.All these preliminary findings prompt us to propose that PVT1 may play an important role in the tumorigenesis and metastasis of HG-SOC. To test our hypothesis, we will first determine the functional effect of PVT1 on tumorigenesis and metastasis of ovarian cancer in vitro and in vivo. Then, RNA pull-down and RIP will be used to identify the proteins that are physically associated with PVT1. And finally, we will examine the expressions of PVT1 and its associated molecules in HG-SOC patient samples to determine whether their expressions are correlated with tumor progression and overall survival. The ultimate goal of this study is to clarify and characterize the functional role of LncRNA-PVT1 in tumorigenesis and metastasis of high-grade serous ovarian carcinomas.
输卵管是低级别和高级别浆液性卵巢癌的共同起源,但是高级别浆液性癌恶性程度更高、预后更差,对比分析两种浆液性肿瘤,揭示高级别浆液性癌恶性行为背后的分子机制具有重要意义。我们前期对两种浆液性癌进行了lncRNA芯片分析,发现lncRNA-PVT1和HMGA1P6在高级别浆液性癌中表达上调。本课题主要围绕这两个长链非编码RNA及其相关的miRNA开展工作。 1. PVT1在高级别浆液性癌(HGSOC)组织中拷贝数增加,,PVT1高表达的患者预后较差。 PVT1可编码miR-1204,miR-1205, miR-1206, miR-1207四个miRNA,PVT1及其编码miRNA在HGSOC显著高表达, PVT1编码miRNAs促进卵巢癌细胞的增殖和侵袭力。2.HMGA1P6在HGSOC中高表达,并促进侵袭及EMT进程。重要的是,我们发现HMGA1P6通过ceRNA机制上调HMGA1和HMGA2的表达,HMGA1P6上游又受到HMGA1的转录激活,形成正反馈调控环路。在本基金的支持下,共发表SCI论文5篇(已标注),其中1篇发表在Cell Death & Differentiation(中科院1区,影响因子8.34),申请国家发明专利1项。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
登录
查看更多内容
Neferine induces autophagy of human ovarian cancer cells via p38 MAPK/ JNK activation
Neferine 通过 p38 MAPK/JNK 激活诱导人卵巢癌细胞自噬
DOI:
10.1007/s13277-015-4737-8
发表时间:
2016-01
期刊:
Tumor Biology
影响因子:
--
作者:
[Xu Limei, Zhang Xiyu, Li Yinuo, Lu Shuhua, Lu Shan, Li Jieyin, Wang Yuqiong, Tian Xiaoxue, Wei Jian-jun, Shao Changshun, Liu Zhaojian]
通讯作者:
Liu Zhaojian
Spliceosome-associated factor CTNNBL1 promotes proliferation and invasion in ovarian cancer
剪接体相关因子 CTNNBL1 促进卵巢癌的增殖和侵袭
DOI:
10.1016/j.yexcr.2017.05.008
发表时间:
2017-08-01
期刊:
EXPERIMENTAL CELL RESEARCH
影响因子:
3.7
作者:
[Li, Yingwei, Guo, Haiyang, Kong, Beihua]
通讯作者:
Kong, Beihua
miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma
miR-130a 在高级别浆液性卵巢癌中通过靶向 TSC1 上调 mTOR 通路并被 NF-κ B 反式激活
DOI:
10.1038/cdd.2017.129
发表时间:
2017-12-01
期刊:
CELL DEATH AND DIFFERENTIATION
影响因子:
12.4
作者:
[Wang, Yuqiong, Zhang, Xiyu, Liu, Zhaojian]
通讯作者:
Liu, Zhaojian
Overexpression of CD47 predicts poor prognosis and promotes cancer cell invasion in high-grade serous ovarian carcinoma.
CD47 的过表达预示着高级别浆液性卵巢癌的不良预后并促进癌细胞侵袭。
DOI:
--
发表时间:
2017
期刊:
American Journal of Translational Research
影响因子:
2.2
作者:
[Li Yinuo, Lu Shuhua, Xu Ying, Qiu Chunping, Jin Chengjuan, Wang Yuqiong, Liu Zhaojian, Kong Beihua]
通讯作者:
Kong Beihua
Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis
HMGA2在子宫内膜浆液性癌发生中的过度表达和致癌功能
DOI:
--
发表时间:
2016
期刊:
American Journal of Cancer Research
影响因子:
5.3
作者:
[Wei Linxuan, Liu Xiaolin, Zhang Wenjing, Wei Yuyan, Li Yingwei, Zhang Qing, Dong Ruifen, Kwon Jungeun Sarah, Liu Zhaojian, Zheng Wenxin, Kong Beihua]
通讯作者:
Kong Beihua
ADAR1诱导的RNA超编辑促进卵巢癌恶性进展的作用和机制
-
批准号:82472792
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2024
-
负责人:刘招舰
-
依托单位:
剪接因子USP39通过调控HMGA2促进卵巢癌侵袭转移的机制
-
批准号:81972437
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:刘招舰
-
依托单位:
剪接因子USP39促进卵巢癌恶性行为的作用及机制
-
批准号:81672578
-
项目类别:面上项目
-
资助金额:50.0万元
-
批准年份:2016
-
负责人:刘招舰
-
依托单位:
miR-182和miR-17家族在输卵管来源高度恶性浆液性癌发生发展过程中的作用和机制
-
批准号:81171897
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:刘招舰
-
依托单位:
国内基金
海外基金